DigitalDx Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

OXcan raises £9m Series A led by We Venture Capital and Cross-Border Impact Ventures to revolutionise early lung cancer detection

9 Jan 2025

OXcan raises £9m Series A led by We Venture Capital and Cross-Border Impact Ventures to revolutionise early lung cancer detection

OXcan develops blood-based liquid biopsy tests using proteomics and AI to detect lung cancer at earlier stages, enabling minimally invasive screening designed to improve outcomes and reduce pressure on healthcare systems.

DigitalDx Ventures

- Life Sciences
digitaldxventures.com
Update Information

More venture news

Combat Medical
12 Mar 2026
Combat Medical raises a £2.6m Series A led by T&J Meyer Family Foundation for hard-to-treat bladder cancer
Series AHealth
Outpost
10 Mar 2026
Outpost unlocks £13m Series A led by Ribbit for cross-border payments and tax compliance infrastructure
Series AFintech
4 Mar 2026
Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation
Series ASupply Chain

DigitalDx Ventures

Investment Portfolio

OXcan raises £9m Series A led by We Venture Capital and Cross-Border Impact Ventures to revolutionise early lung cancer detection

More venture news

Combat Medical raises a £2.6m Series A led by T&J Meyer Family Foundation for hard-to-treat bladder cancer

Outpost unlocks £13m Series A led by Ribbit for cross-border payments and tax compliance infrastructure

Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation